Literature DB >> 15533219

Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.

J V Bagán1, K Thongprasom, C Scully.   

Abstract

Rofecoxib is an inhibitor of the enzyme cyclo-oxygenase 2 (COX-2) used as an analgesic and anti-inflammatory agent especially in rheumatoid arthritis and osteoarthritis. The adverse effects are generally less than with other anti-inflammatory drugs (NSAIDs), and no oral adverse reactions have been reported in the literature. We present three cases of oral lesions caused by rofecoxib. Extensive erosions appeared, which in all cases resolved on withdrawal of the drug.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15533219     DOI： 10.1111/j.1601-0825.2004.01024.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN： 1354-523X            Impact factor:   3.511


  7 in total

1.  Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report.

Authors:  Pratanporn Arirachakaran; Mattana Hanvanich; Piyanad Kuysakorn; Kobkan Thongprasom
Journal:  Int J Dent       Date:  2010-07-05

2.  Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report.

Authors:  Kobkan Thongprasom; Somchai Sessririsombat; Kanjana Singkharotai; Achara Vathanasanti; Keskanya Subbalek
Journal:  Acta Stomatol Croat       Date:  2014-09

Review 3.  Oral lichenoid lesions - a review and update.

Authors:  Venkatesh Vishwanath Kamath; Krishnanand Setlur; Komali Yerlagudda
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

4.  Oral and vulvo-vaginal lichenoid reactions due to mitotane (Lysodren): A case report.

Authors:  Arthur Schmouchkovitch; Héloïse Herry; Philippe Thuillier; Véronique Kerlan; Camille Fleuret; Guy Le Toux; Sylvie Boisramé
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 5.  A Review of the Effectiveness and Side-Effects of Fluocinolone Acetonide 0.1% in the Treatment of Oral Mucosal Diseases.

Authors:  Kobkan Thongprasom
Journal:  Acta Stomatol Croat       Date:  2017-09

6.  Dysbiosis of saliva microbiome in patients with oral lichen planus.

Authors:  Fei Yan Yu; Qian Qian Wang; Miao Li; Ya-Hsin Cheng; Yi-Shing Lisa Cheng; Yu Zhou; Xi Yang; Fang Zhang; Xuejun Ge; Bin Zhao; Xiu Yun Ren
Journal:  BMC Microbiol       Date:  2020-04-03       Impact factor: 3.605

7.  Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats.

Authors:  Mark C Heit; L Jay Stallons; Wolfgang Seewald; Caryn M Thompson; Céline E Toutain; Stephen B King; Rainer Helbig
Journal:  BMC Vet Res       Date:  2020-09-25       Impact factor: 2.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.